Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in April. Here is a list of some of the biggest funding rounds.
Chapter raises $100 million in Series E funding
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
The New York-based company offers a Medicare navigation platform. Its AI platform compares health plans from every insurance carrier, including Humana, UnitedHealthcare and Cigna. Seniors using the platform can either talk to a Chapter Medicare advisor to help choose a plan or explore plans on their own. It also offers a provider directory and prescription cost calculator for Medicare.
Chapter’s Series E round was led by Generation Investment Management, with participation from Fifth Down Capital, 8VC, Stripes, XYZ Venture Capital, Addition, Narya Capital, Susa Ventures and Maverick Ventures. The funding brings Chapter’s valuation to $3 billion, and it has raised $285 million in total.
AcuityMD secures $80 million in Series C funding
AcuityMD is an AI platform for medtech companies. It helps them accelerate product adoption, drive revenue growth and operate more efficiently at scale. It has served more than 400 medical device companies.
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The Series C round was led by StepStone Group, with additional participation from Benchmark, Redpoint Ventures, ICONIQ and Atreides Management. In total, AcuityMD has raised more than $160 million and is valued at $955 million.
Courier Health raises $50 million in Series B funding
Courier Health aims to “reinvent” how people with chronic and rare diseases are supported. Its software is used by biopharma companies to help patients from diagnosis to starting and staying on therapy.
The company’s Series B round was led by Oak HC/FT, with participation from Norwest and Work-Bench. It will be used to support “continued product innovation,” according to the announcement.
Cala Health secures $50 million in funding
Cala Health offers an FDA-cleared wearable device that helps patients manage hand tremors. The device is worn on the wrist and measures the patient’s tremor pattern to then provide nerve stimulation that counteracts the tremors.
Its $50 million raise was from Trinity Capital, an international alternative asset manager. Rob Lake, senior managing director of life sciences at Trinity Capital, said in a statement that Cala Health has “developed a therapy that we believe is simple, personalized, and effective for patients.”
Photo: Andriy Onufriyenko, Getty Images